肺炎克雷伯菌的异质性耐药

Heterogeneous Resistance of Klebsiella pneumoniae

摘要: 克雷伯菌属中的肺炎克雷伯菌(Klebsiella pneumoniae, KP)，分类上隶属于肠杆菌科。该菌能够引发包括肺部、泌尿系统、血液系统以及中枢神经系统等多个关键部位的感染。在社区及医院环境中，该菌种均呈现出较高的流行率，是引发院内感染的主要病原体之一。近些年来，由于抗生素的不合理使用以及在基层医院的广泛运用，KP对抗生素的耐药率不断上升且广泛传播。除了展现出对广谱抗生素的耐药特性之外，KP还表现出一种被称为异质性耐药的现象。此现象具体指的是，在同一细菌群体中，不同亚群对同一抗生素的敏感性表现出显著差异，这一现象被视为细菌由敏感状态向全面耐药状态过渡的关键阶段。由于KP异质性耐药在表型与遗传特征上的高度不稳定性，常规的临床检测手段难以准确捕捉这种耐药特性，从而对临床用药决策构成了严峻挑战，增加了患者遭受重复感染及治疗失效的风险。所以，对KP异质性耐药进行研究，对于预防和控制细菌耐药以及指导临床用药具有重大意义，也有助于了解临床常见分离菌的耐药发展进程。本论文旨在概述肺炎克雷伯菌(Klebsiella pneumoniae，简称KP)异质性耐药性的概念界定、鉴别技术手段、潜在的耐药机理及其潜在的治疗干预策略。通过对这些方面的综合分析，本研究期望为深入理解KP异质性耐药现象提供理论支撑，并为临床治疗中应对此类耐药菌提供策略参考。

Abstract: Klebsiella pneumoniae (KP) belongs to the genus Klebsiella of the family Enterobacteriaceae and can cause infections in multiple sites, including pneumonia, the urinary tract, the blood, and the brain, etc. It is prevalent in community environments and is one of the most common pathogens that cause hospital-acquired infections. In recent years, with the irrational application of antibiotics and the widespread use of primary hospitals, the resistance rate of Klebsiella pneumoniae to antibiotics has increased year by year and become widely prevalent, and in addition to resistance to antibiotics, heterogeneous resistance to a variety of antibiotics has also been found. Heterogeneous resistance refers to homogeneous subgroups of bacteria that exhibit different sensitivities to a particular antibiotic and is considered to be an intermediate stage in the evolution of bacteria from sensitivity to complete resistance. Due to the phenotypic and genotypic instability of heterogeneous resistance in Klebsiella pneumoniae, heterogeneous resistance cannot be effectively detected by conventional clinical tests, which poses a great threat to the clinical therapeutic use of medication and is prone to cause recurrent infections and medication failure in patients. Therefore, the study of heterogeneous drug resistance in Klebsiella pneumoniae is of great significance for the prevention and control of bacterial drug resistance as well as the guidance of clinical medication, and it also helps to understand the process of drug resistance development of common clinical isolates. In this paper, the definition of Klebsiella pneumoniae heterogeneity, detection methods, possible resistance mechanisms, potential therapeutic strategies, and future perspectives are reviewed as follows. By comprehensively analyzing these aspects, this study expects to provide theoretical support for an in-depth understanding of the phenomenon of KP heterogeneous drug resistance and to provide strategic references for coping with such drug-resistant bacteria in clinical treatment.